Figure 1
Flowchart of the sample. CLI, critical limb ischemia; DPP-4, dipeptidyl peptidase 4 inhibitors; GLP-1, glucagon-like peptide 1 analogues; PVD, peripheral vascular disease; SGLT-2, sodium-glucose cotransporter 2 inhibitors. *Patients.
Figure 1 | Scientific Reports
